OSR Health (OSRHW) Change in Account Payables (2024 - 2026)
OSR Health (OSRHW) posted Change in Account Payables of $11449.3 for Q1 2026, down 84.64% sequentially from $74520.0 in Q4 2025, and down 48.79% YoY from $22356.4 in Q1 2025.
OSR Health (OSRHW) Change in Account Payables (2024 - 2026) Analysis & Trends
OSR Health has reported Change in Account Payables for 3 years, with the latest figure at $11449.3 in Q1 2026.
- Quarterly Change in Account Payables fell 48.79% year-over-year to $11449.3 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$521139.1 (down 1591.04% YoY) and the FY2025 annual result came in at -$510232.0, down 48.31% from the prior year.
- Change in Account Payables eased to $11449.3 in Q1 2026 per OSRHW's latest filing, from $74520.0 in the prior quarter.
- Over five years, Change in Account Payables peaked at $1.0 million in Q2 2025 and troughed at -$1.6 million in Q3 2025.
- A 3-year average of -$93646.1 and a median of $11449.3 in 2026 frame the typical range for Change in Account Payables.
- The widest YoY moves for Change in Account Payables: up 495.45% in 2025, down 3350.86% in 2025.
- Over 3 years, Change in Account Payables stood at $248812.0 in 2024, then sank by 70.05% to $74520.0 in 2025, then plunged by 84.64% to $11449.3 in 2026.
- According to Business Quant data, Change in Account Payables over the past three periods registered $11449.3, $74520.0, and -$1.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.97 Bn | 131.12 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.15 Bn | 77.15 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 62.84 Bn | 57.65 Bn | 1.37 Bn | - |
| 4 | Moderna | 55.74 Bn | 50.60 Bn | 52.00 Mn | -8.00 Mn |
| 5 | BeOne Medicines | 41.53 Bn | 36.43 Bn | 1.53 Bn | 37.53 Mn |
| 6 | Alnylam Pharmaceuticals | 31.60 Bn | 28.29 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.32 Bn | 8.93 Bn | 668.28 Mn | - |
| 8 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | - |
| 9 | Insmed | 26.99 Bn | 25.83 Bn | 358.27 Mn | - |
| 10 | OSR Health | 1.40 Mn | 20.39 Mn | 86,605.00 | -970,159.29 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11,449.29 |
| Mar 31, 2026 | 11,449.29 |
| Dec 31, 2025 | 74,520.00 |
| Dec 31, 2025 | 74,520.00 |
| Sep 30, 2025 | -1.62 Mn |
| Sep 30, 2025 | -1.62 Mn |
| Jun 30, 2025 | 1.01 Mn |
| Jun 30, 2025 | 1.01 Mn |
| Mar 31, 2025 | 22,356.35 |
| Mar 31, 2025 | 22,356.35 |
| Dec 31, 2024 | 248,812.00 |
| Dec 31, 2024 | 248,812.00 |
| Sep 30, 2024 | -46,832.00 |
| Sep 30, 2024 | -46,832.00 |
| Jun 30, 2024 | -255,154.00 |
| Jun 30, 2024 | -255,154.00 |
| Mar 31, 2024 | -290,858.00 |
| Mar 31, 2024 | -290,858.00 |